These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3094463)

  • 41. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peripheral lymphocyte depletion in gold sodium thiomalate-treated rheumatoid arthritis patients.
    Lundberg MS; Cannon GW; Ward JR
    Arthritis Rheum; 1988 Jul; 31(7):909-13. PubMed ID: 3134898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myocrisin.
    Capell HA
    Agents Actions Suppl; 1988; 24():158-66. PubMed ID: 3142232
    [No Abstract]   [Full Text] [Related]  

  • 46. Gold(I) ion and the phosphine ligand are necessary for the anti-
    Ma CI; Tirtorahardjo JA; Schweizer SS; Zhang J; Fang Z; Xing L; Xu M; Herman DA; Kleinman MT; McCullough BS; Barrios AM; Andrade RM
    Microbiol Spectr; 2024 Feb; 12(2):e0296823. PubMed ID: 38206030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic gold therapy.
    Papp KA; Shear NH
    Clin Dermatol; 1991; 9(4):535-51. PubMed ID: 1822410
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral gold in rheumatoid arthritis.
    Drug Ther Bull; 1988 Sep; 26(18):69-72. PubMed ID: 3139386
    [No Abstract]   [Full Text] [Related]  

  • 49. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
    McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN
    Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of auranofin on the radiological progression of joint erosion in rheumatoid arthritis.
    Gofton JP; O'Brien WM
    J Rheumatol Suppl; 1982; 8():169-72. PubMed ID: 6813480
    [No Abstract]   [Full Text] [Related]  

  • 51. Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis.
    Glennås A; Kvien TK; Andrup O; Clarke-Jenssen O; Karstensen B; Brodin U
    Br J Rheumatol; 1997 Aug; 36(8):870-7. PubMed ID: 9291856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 53. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
    Tumiati B; Veneziani M; Bellelli A; Portioli I
    J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
    [No Abstract]   [Full Text] [Related]  

  • 54. Gold--by mouth?
    Symmons D
    J Clin Pharm Ther; 1989 Aug; 14(4):243-5. PubMed ID: 2571615
    [No Abstract]   [Full Text] [Related]  

  • 55. Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin.
    Prete PE; Zane J; Krailo M; Bulanowski M
    Clin Rheumatol; 1994 Mar; 13(1):60-9. PubMed ID: 8187446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M; McCain GA; Orange JF
    J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Partial cross-resistance between auranofin and sodium aurothiomalate in cultured human cells.
    Rugstad HE; Glennås A
    Scand J Rheumatol; 1988; 17(3):175-81. PubMed ID: 3140371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 6. Bucillamine and gold (gold sodium thiomalate and auranofin)].
    Ito S
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2936-41. PubMed ID: 22175134
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical assessment of a group of children with juvenile rheumatoid arthritis receiving long-term treatment with oral gold salt].
    Mignone F; Sardella ML; Clara L; Barrett S; Basano R; Barbero I
    Minerva Pediatr; 1992 Dec; 44(12):617-22. PubMed ID: 1363792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.